Sahli, R

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Journal Article

Krull, I; Sahli, R; Diem, P; Stettler, C (2009). Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays. Diabetic medicine, 26(10), pp. 1075-6. Chichester: Wiley 10.1111/j.1464-5491.2009.02815.x

Sahli, R; Christ, E (2008). [Pregnancy in active acromegaly]. Deutsche medizinische Wochenschrift, 133(45), pp. 2328-31. Stuttgart: Thieme 10.1055/s-0028-1100923

Arnedo, M; Taffé, P; Sahli, R; Furrer, H; Hirschel, B; Elzi, L; Weber, R; Vernazza, P; Bernasconi, E; Darioli, R; Bergmann, S; Beckmann, JS; Telenti, A; Tarr, PE; Swiss, HIV Cohort Study (2007). Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenetics and genomics, 17(9), pp. 755-64. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e32814db8b7

Sahli, R; Diem, P; Christ, ER (2005). [Endogenous hypercortisolism and immunologically-mediated disease: three cases]. Deutsche medizinische Wochenschrift, 130(41), pp. 2316-8. Stuttgart: Thieme 10.1055/s-2005-918569

Conference or Workshop Item

Egli-Gany, D; Spaar, A; Masserey Spicher, V; Diebold, J; Sahli, R; Heusser, R; Frey Tirri, B; Petignat, P; Low, Nicola (8 October 2017). P36-05 HPV prevalence and associated risk factors in women with cervical pre-cancer and cancer in Switzerland at the beginning of the cantonal vaccination programmes: The CIN3+plus study. In: Eurogin. Amsterdam: European Reserch Organisation on Genital Infection and Neoplasia

Egli-Gany, D; Spaar, A; Masserey Spicher, V; Diebold, J; Sahli, R; Heusser, R; Frey Tirri, B; Petignat, P; Low, Nicola (8 October 2017). Human Papillomavirus prevalence and associated risk factors in women with cervical pre-cancer and cancer in Switzerland at the beginning of the cantonal vaccination programmes: The CIN3+plus study. In: Annual Congress gynécololgie suisse. Lausanne. 28-30 June 2017.

This list was generated on Tue Dec 3 18:34:32 2024 CET.
Provide Feedback